Df Dent & CO Inc West Pharmaceutical Services Inc Transaction History

Df Dent & CO Inc

$7.21 Billion
Q2 2025

A detailed history of Df Dent & CO Inc transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Df Dent & CO Inc holds 395,274 shares of WST stock, worth $111 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

395,274

Previous 439,298 10.02%

Holding current value

$111 Million

Previous $98.4 Million 12.06%

% of portfolio

1.2%

Previous 1.43%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$190.39 - $227.7 $8.38 Million - $10 Million	-44,024 Reduced 10.02%	395,274 $86.5 Million
Q1 2025 May 15, 2025	BUY	$199.11 - $347.87 $8.4 Million - $14.7 Million	42,202 Added 10.63%	439,298 $98.4 Million
Q4 2024 Feb 12, 2025	SELL	$285.69 - $344.0 $15,998 - $19,264	-56 Reduced 0.01%	397,096 $130 Million
Q3 2024 Nov 14, 2024	BUY	$277.16 - $333.3 $27.3 Million - $32.9 Million	98,564 Added 33.01%	397,152 $119 Million
Q2 2024 Aug 14, 2024	BUY	$314.68 - $395.94 $12.2 Million - $15.3 Million	38,654 Added 14.87%	298,588 $98.4 Million
Q1 2024 May 15, 2024	BUY	$338.27 - $413.0 $61.7 Million - $75.3 Million	182,443 Added 235.44%	259,934 $103 Million
Q4 2023 Feb 14, 2024	SELL	$318.29 - $392.21 $717,743 - $884,433	-2,255 Reduced 2.83%	77,491 $27.3 Million
Q2 2023 Aug 14, 2023	BUY	$334.63 - $382.47 $971,096 - $1.11 Million	2,902 Added 3.78%	79,746 $30.5 Million
Q1 2023 May 15, 2023	SELL	$232.5 - $346.47 $71,377 - $106,366	-307 Reduced 0.4%	76,844 $26.6 Million
Q4 2022 Feb 15, 2023	BUY	$209.34 - $261.61 $16.2 Million - $20.2 Million	77,151 New	77,151 $18.2 Million

Others Institutions Holding WST

# of Institutions

842

Shares Held

68.6M

Call Options Held

344K

Put Options Held

144K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $20.9B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.

Account